Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis

BACKGROUND: There are no proven therapies that modify the structural changes associated with osteoarthritis (OA). Preclinical data suggests that intra-articular recombinant human BMP-7 (bone morphogenetic protein-7) has reparative effects on cartilage, as well as on symptoms of joint pain. The objec...

Descripción completa

Detalles Bibliográficos
Autores principales: Hunter, David J, Pike, Marilyn C, Jonas, Beth L, Kissin, Eugene, Krop, Julie, McAlindon, Tim
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958989/
https://www.ncbi.nlm.nih.gov/pubmed/20932341
http://dx.doi.org/10.1186/1471-2474-11-232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958989/
https://www.ncbi.nlm.nih.gov/pubmed/20932341
http://dx.doi.org/10.1186/1471-2474-11-232

Ejemplares similares